Background Image
Table of Contents Table of Contents
Previous Page  33 / 66 Next Page
Basic version Information
Show Menu
Previous Page 33 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 6, November/December 2014

AFRICA

283

of 23.7% of the cohort.

Thirty-three patients in the cohort were male and 26 were

female. Age ranged from 16 to 82 years (mean: 51.9 years).

Thirty-four patients were of Indian descent, while 17 were

black and the remaining eight were white patients. The majority

(79.4%) of Indian patients had coronary surgery alone or in

combination with valve surgery. Fifty-four patients had elective

surgery and five had surgery on an emergency basis.

RGW ranged from the institutional norm of two days up to a

maximum of 24 days. The mean RGW duration was 6.6 days (

n

=

54). Six patients died during the index admission period, three

of whom had emergency surgery.

Twenty-four patients were diabetic and 35 had hypertension.

Twenty patients had both diabetes and hypertension.

Thirty-seven patients used

β

-blockers and 40 were on statin

therapy on a chronic basis. Thirty-two patients in the cohort

used a combination of statins and

β

-blockers prior to surgery.

β

-blockers were withdrawn in only three patients in the immediate

pre-operative period.

Miscellaneous risk factors were BMI, previous cardiac

surgery and smoking. The BMI ranged from 17 to 42 kg/m

2

,with

a mean of 26.4 kg/m

2

(

n

=

54). Three patients in the cohort had

prior cardiac surgery. Twelve patients were still smoking in the

immediate pre-operative period. The echocardiographic results

are reflected in Table 2.

An analysis of the subgroup of patients (

n

=

33) who

underwent coronary artery surgery alone or in combination

with valve surgery is as follows: mean age was 62.2 years, there

were 26 male and seven female, mean BMI (

n

=

31) was 26.9

kg/m

2

, 33 patients were on statins and 31 on

β

-blockers. Mean

echocardiographic parameters (

n

=

27): LVD

=

56.3 mm, LA

=

45.9 mm, EF

=

51.6%.

The coronary patients were a mean of 10.3 years older than

the whole cohort and 78.8% were male. The other parameters

closely resembled that of the entire cohort.

The majority of patients (64.4%) developed AF from day

three onwards. The incidence of AF in the individual post-

operative time periods is reflected in Fig. 1. The various

individual and combination treatment modalities used to treat

AF after cardiac surgery is shown in Fig. 2.

Follow-up data was available for 40 patients at the time

of data presentation. Follow-up duration ranged from 1.5 to

38 months after surgery, with a mean of 16.1 months. At the

follow-up visit, all 40 patients were in sinus rhythm. Twenty-two

patients were at that stage noted to be using

β

-blocker therapy

for underlying chronic cardiac conditions.

Discussion

De novo

atrial fibrillation post cardiac surgery is a post-

operative complication associated with significant morbidity

and mortality.

3

Hakala

et al.

demonstrated, in a retrospective

study of 3 676 Finnish patients, an increase in peri-operative

cardiovascular accidents (CVA), confusion, ICU LOS and ICU

re-admission rates.

4

Almassi

et al.

showed significantly higher

Table 1. Incidence of AF per surgical procedure

Type of surgery

Number

develop-

ing AF

Total

number

of

surgeries

Percent-

age of

cohort

(%)

Coronary surgery

Coronary artery bypass graft surgery

(CABG)

13

270 45.8

Off-pump coronary bypass surgery

(OPCAB)

14

251

Valve surgery

Mitral valve replacement (MVR)

7

251 44.1

Aortic valve replacement (AVR)

11

85

Double valve replacement (DVR)

8

113

Combination coronary and valve surgery

CABG + MVR

0

12 10.2

CABG + AVR

6

12

CABG + DVR

0

3

Total

59

997

Table 2. Echocardiographic parameters

Parameter

Patient number

Range

Mean

LVD (mm)

50

42–75

56.1

LA (mm)

50

33–90

51

EF (%)

52

25–66

52.8

<

24 hours

(

n

=

6)

>

48 hours

(

n

=

38)

24–48 hours

(

n

=

15)

Fig. 1.

Timing of AF presentation.

Spont-

aneous

resolution

Cardio-

version

and amio-

darone

Amio-

darone

only

Cardio-

version

only

Cardio-

version and

other anti-

arrythmic

drug

Other anti-

arrythmic

drug only

Modality

40

35

30

25

20

15

10

5

0

Number of patients (

n

= 59)

1

35

7

9

5

2

Fig. 2.

Modalities used to treat AF.